Lack of multiple dosing effect of sertindole on the pharmacokinetics of alprazolam in healthy volunteers

Psychopharmacology

Volumn 135, Issue 3, 1998, Pages 236-241

  Wong, S L ^a   Locke, C ^a   Staser, J ^a   Granneman, G R ^a  

^a ABBOTT LABORATORIES   (United States)

Author keywords

Alprazolam; Interactions; Pharmacokinetics; Schizophrenia; Sertindole

Indexed keywords

ALPRAZOLAM; CYTOCHROME P450; SERTINDOLE;

ADULT; AREA UNDER THE CURVE; ARTICLE; BIOAVAILABILITY; CLINICAL TRIAL; DRUG BLOOD LEVEL; DRUG HALF LIFE; ENZYME INHIBITION; FEMALE; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; PHARMACOKINETICS; PRIORITY JOURNAL; SCHIZOPHRENIA; VOLUNTEER;

ADULT; ALPRAZOLAM; ANTI-ANXIETY AGENTS; ANTIPSYCHOTIC AGENTS; AREA UNDER CURVE; CYTOCHROME P-450 CYP2D6; DRUG INTERACTIONS; FEMALE; GENOTYPE; HALF-LIFE; HUMANS; IMIDAZOLES; INDOLES; MALE;

EID: 0031973740     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002130050505     Document Type: Article

References (18)

1. Carson SW, Wright CE, Millikin SP, Lyon J, Chambers JH (1992) Pharmacokinetic evaluations of the combined administration of alprazolam and clomipriamine. (Abstract). Meeting of the American Society for Clinical Pharmacology and Ther, March 18-20. Clin Pharmacol Ther 51:154
2. Casey DE, Targum S, Zimbroff D et al. (1995) Efficacy, safety, and dose response of three doses of sertindole and three doses of haldol in schizophrenic patients. (Abstract). Meeting of the American College of Neuropsychopharmacology. Dec 10-15
3. Ciraulo DA, Antal EJ, Smith RB, Oslon DR, Goldberg DA et al. (1990) The relationship of alprazolam dose to steady-state plasma concentrations. J Clin Psychopharmacol 10:27-32
4. Gibaldi M, Perrier D (1982) Pharmacokinetics. 2nd edn. Marcel Dekker, New York
5. Greenblatt DJ, Wright CE (1993) Clinical pharmacokinetics of alprazolam: therapeutic implications. Clin Pharmacokin 24:453-471
6. Greenblatt DJ, Javaid JI, Locniskar A, Harmatz JS, Shader RI (1990) Gas chromatographic analysis of alprazolam in plasma: replicability, stability, and specificity. J Chromatogr 534: 202-207
7. Greenblatt DJ, von Moltke LL, Schmider J, Harmatz JS, Shader RI (1996) Inhibition of human cytochrome P450-3A isoforms by fluoxetine and norfluoxetine: in vitro and in vivo studies. J Clin Pharmacol 36:792-798
8. Heim M, Meyer UA (1991) Genetic polymorphism of debrisoquine oxidation: analysis of mutant alleles of CYP2D6 by restriction fragment analysis and by allele specific amplication. Methods Enzymol 206:173-183
9. Kronbach T, Mathys D, Umeno M, Gonzalez KJ, Meyer UA (1989) Oxidation of midazolam and triazolam by cytochrome P450 III A4. Mol Pharmacol 36:89-96
10. Sakamoto K, Nakamura Y, Aikoh S, Baba T, Perregaard J, Pedersen H, Moltzen EK, Mulford DJ, Yamaguchi T (1995) Metabolism of sertindole: identification of the metabolites in the rat and dog, and species comparison of liver microsomal metabolism. Xenobiotica 25:1327-1343
11. Schulz C, Staser J, Schmitz P, Mack R, Sebree T (1994) An open-label assessment of the long-term safety of sertindole in the treatment of schizophrenic patient. Marcus Wallenberg Symposium on schizophrenia. Gothenberg, Sweden, September
12. Smith RB, Kroboth PD, Vanderlugt JT, Philips JP, Juhl RP (1984) Pharmacokinetics and pharmacodynainics of alprazolam after oral and IV administration. Psychopharmacology 84: 452-456
13. VanKammen DP, McEvoy JP, Targum SD, Kardatke D, Sebree TB (1996) A randomized, controlled, dose-ranging trial of sertindole in patients with schizophrenia. Psychopharmacology 124:168-175
14. von Moltke LL, Greenblatt DJ, Cotreau-Bibbo MM, Harmatz JS, Shader RI (1994) Inhibitors of alprazolam metabolism in vitro: effect of serotonin-reuptake-inhibitor antidepressants, ketoconazole and quinidine. Br J Clin Pharmacol 38:23-31
15. von Moltke LL, Greenblatt DJ, Court MH, Duan SX, Harmatz JS, Shader RI (1995) Inhibition of alprazolam and desipramine in vitro by paroxetine and fluvoxamine: comparison with other selective serotonin reuptake inhibitor antidepressants. J Clin Psychopharmacol 15:125-131
16. Wong SL, Linnen P, Mack R, Granneman GR (1997a) Effects of food, antacid, and dosage form on the pharmacokinetics and relative bioavailability of sertindole in healthy volunteers. Biopharm Drug Dispos 18:533-541
17. Wong SL, Menacherry S, Mulford D, Schmitz P, Locke C, Granneman GR (1997b) Pharmacokinetics of sertindole and dehydrosertindole in volunteers with normal or impaired renal function. Eur J Clin Pharmacol 52:223-227
18. Yasui N, Otani K, Kaneko S, Ohkubo T, Osanai T, Sugawara K, Chiba K, Ishizaki T (1996) A kinetic and dynamic study of oral alpruzolam with and without erythromycin in humans: in vivo evidence for the involvement of CYP3A4 in alprazolam metabolism. Clin Pharmacol Ther 59:514-519